Use of the bromine isotope ratio in HPLC-ICP-MS and HPLC-ESI-MS analysis of a new drug in development.
第一作者:
Filip,Cuyckens
第一单位:
Global Preclinical Development, Johnson & Johnson Pharmaceutical R&D, Turnhoutseweg 30, 2340, Beerse, Belgium.
作者:
医学主题词
投药, 口服(Administration, Oral);动物(Animals);抗结核药(Antitubercular Agents);溴(Bromine);色谱法, 高压液相(Chromatography, High Pressure Liquid);狗(Dogs);药物设计(Drug Design);同位素(Isotopes);男(雄)性(Male);质谱分析法(Mass Spectrometry);分子结构(Molecular Structure);喹啉类(Quinolines);大鼠(Rats);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);结果可重复性(Reproducibility of Results);敏感性与特异性(Sensitivity and Specificity);光谱法, 质量, 电喷雾电离(Spectrometry, Mass, Electrospray Ionization);时间因素(Time Factors)
DOI
10.1007/s00216-007-1761-6
PMID
18172622
发布时间
2016-05-12
- 浏览104
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



